QUOTED. 24 November 2020. Kees Wesdorp.
Executive Summary
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
“COVID-19 has become a defining moment for all of us to reimagine health care the way it should be.” – Kees Wesdorp, chief business leader of precision diagnosis, Royal Philips
- Find out more: Advancing The Precision Mission At RSNA 2020
Click here for a free trial of Medtech Insight